-
- Kai Eriksson, Tapani Keränen, and Reetta Kälviäinen.
- Docent University of Tampere, Tampere University Hospital, Pediatric Neurology Unit, Pediatric Research Centre, Tampere, Finland. kai.eriksson@uta.fi
- Expert Opin Drug Metab Toxicol. 2009 Jun 1;5(6):695-701.
BackgroundFosphenytoin, phosphate ester pro-drug of phenytoin, was developed to overcome complications associated with parenteral phenytoin administration in treatment of acute symptomatic seizures, short-term prophylaxis and treatment of repetitive or prolonged seizures and status epilepticus.ObjectiveTo evaluate the current position of fosphenytoin in treatment algorithms compared to phenytoin.MethodsThis review focuses on pharmacokinetics and dynamics, clinical efficacy and tolerability of fosphenytoin in children and adults.ConclusionPublished literature shows that intravenous fosphenytoin has a similar adverse effect profile than phenytoin when it is administered as recommended. There is no evidence of clear benefit that would justify the higher price of the fosphenytoin compared to phenytoin.
Notes
Knowledge, pearl, summary or comment to share?You can also include formatting, links, images and footnotes in your notes
- Simple formatting can be added to notes, such as
*italics*,_underline_or**bold**. - Superscript can be denoted by
<sup>text</sup>and subscript<sub>text</sub>. - Numbered or bulleted lists can be created using either numbered lines
1. 2. 3., hyphens-or asterisks*. - Links can be included with:
[my link to pubmed](http://pubmed.com) - Images can be included with:
 - For footnotes use
[^1](This is a footnote.)inline. - Or use an inline reference
[^1]to refer to a longer footnote elseweher in the document[^1]: This is a long footnote..